692
Views
24
CrossRef citations to date
0
Altmetric
Reviews

The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias

, , & , PhD
Pages 889-903 | Published online: 24 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alexander J. Winkle, Drew M. Nassal, Rebecca Shaheen, Evelyn Thomas, Shivangi Mohta, Daniel Gratz, Seth H. Weinberg & Thomas J. Hund. (2022) Emerging therapeutic targets for cardiac hypertrophy. Expert Opinion on Therapeutic Targets 26:1, pages 29-40.
Read now
Harmen G. Booij, Anne M. Koning, Harry van Goor, Rudolf A. de Boer & B. Daan Westenbrink. (2017) Selecting heart failure patients for metabolic interventions. Expert Review of Molecular Diagnostics 17:2, pages 141-152.
Read now

Articles from other publishers (22)

Niyati Parekh, Sarthak Lakhani, Ayushi Patel, Dhyanesh Oza, Bhumika Patel, Ruchi Yadav & Udit Chaube. (2023) Discovery of novel CaMK-II inhibitor for the possible mitigation of arrhythmia through pharmacophore modelling, virtual screening, molecular docking, and toxicity prediction. Artificial Intelligence Chemistry 1:2, pages 100009.
Crossref
Erin Sanders & Pilar Alcaide. (2023) Red light-green light: T-cell trafficking in cardiac and vascular inflammation. American Journal of Physiology-Cell Physiology 324:1, pages C58-C66.
Crossref
Ali Khalilimeybodi, Muhammad Riaz, Stuart G. Campbell, Jeffrey H. Omens, Andrew D. McCulloch, Yibing Qyang & Jeffrey J. Saucerman. (2023) Signaling network model of cardiomyocyte morphological changes in familial cardiomyopathy. Journal of Molecular and Cellular Cardiology 174, pages 1-14.
Crossref
Dongdong Qian, Jing Tian, Sining Wang, Xiaoli Shan, Pei Zhao, Huihua Chen, Ming Xu, Wei Guo, Chen Zhang & Rong Lu. (2022) Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway. BMC Complementary Medicine and Therapies 22:1.
Crossref
Daan Nie, Chaorui Xia, Zhiyu Wang, Peiwu Ding, Yidi Meng, Jie Liu, Ting Li, Ting Gan, Baijun Xuan, Yun Huang, Jiaming Zhang, Guanhua Su & Jingdong Li. (2022) CaMKII inhibition protects against hyperthyroid arrhythmias and adverse myocardial remodeling. Biochemical and Biophysical Research Communications 615, pages 136-142.
Crossref
Mitchell Simon, Christopher Y. Ko, Robyn T. Rebbeck, Sonya Baidar, Razvan L. Cornea & Donald M. Bers. (2021) CaMKIIδ post-translational modifications increase affinity for calmodulin inside cardiac ventricular myocytes. Journal of Molecular and Cellular Cardiology 161, pages 53-61.
Crossref
Drew M. Nassal, Nehal J. Patel, Sathya D. Unudurthi, Rebecca Shaheen, Jane Yu, Peter J. Mohler & Thomas J. Hund. (2021) Ca2+/calmodulin kinase II–dependent regulation of βIV-spectrin modulates cardiac fibroblast gene expression, proliferation, and contractility. Journal of Biological Chemistry 297:1, pages 100893.
Crossref
Mario G. Pavez-Giani, Pablo I. Sánchez-Aguilera, Nils Bomer, Shigeki Miyamoto, Harmen G. Booij, Paula Giraldo, Silke U. Oberdorf-Maass, Kirsten T. Nijholt, Salva R. Yurista, Hendrik Milting, Peter van der Meer, Rudolf A. de Boer, Joan Heller Brown, Herman W. H. Sillje & B. Daan Westenbrink. (2021) ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ. International Journal of Molecular Sciences 22:9, pages 4427.
Crossref
Salva R. Yurista, Herman H. W. Silljé, Michiel Rienstra, Rudolf A. de Boer & B. Daan Westenbrink. (2020) Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?. Cardiovascular Diabetology 19:1.
Crossref
Drew Nassal, Daniel Gratz & Thomas J. Hund. (2020) Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart. Frontiers in Pharmacology 11.
Crossref
Jung-Hoon Pyun, Hyun-Ji Kim, Myong-Ho Jeong, Byeong-Yun Ahn, Tuan Anh Vuong, Dong I. Lee, Seri Choi, Seung-Hoi Koo, Hana Cho & Jong-Sun Kang. (2018) Cardiac specific PRMT1 ablation causes heart failure through CaMKII dysregulation. Nature Communications 9:1.
Crossref
Daniel M. Johnson & Gudrun Antoons. (2018) Arrhythmogenic Mechanisms in Heart Failure: Linking β-Adrenergic Stimulation, Stretch, and Calcium. Frontiers in Physiology 9.
Crossref
Friederike Cuello & Kristina Lorenz. (2016) Inhibition of cardiac CaMKII to cure heart failure: step by step towards translation?. Basic Research in Cardiology 111:6.
Crossref
Károly Acsai, Balázs Ördög, András Varró & Péter P. Nánási. (2016) Role of the dysfunctional ryanodine receptor - Na+-Ca2+exchanger axis in progression of cardiovascular diseases: What we can learn from pharmacological studies?. European Journal of Pharmacology 779, pages 91-101.
Crossref
Mariya Kronlage, Hugo A. Katus & Johannes Backs. 2016. Epigenetics in Cardiac Disease. Epigenetics in Cardiac Disease 191 208 .
Lorna Daniels, James R. Bell, Lea M. D. Delbridge, Fiona J. McDonald, Regis R. Lamberts & Jeffrey R. Erickson. (2015) The role of CaMKII in diabetic heart dysfunction. Heart Failure Reviews 20:5, pages 589-600.
Crossref
Hui Wang, Yimu Lai, Bryan J. Mathis, Wenjuan Wang, Siying Li, Chen Qu, Bin Li, Lei Shao, Haibo Song, Joseph S. Janicki, Sao-Cong Sun, Xing Li Wang, Dongqi Tang & Taixing Cui. (2015) Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2. Journal of Molecular and Cellular Cardiology 84, pages 143-153.
Crossref
Ralph J. van Oort, Joan Heller Brown & B. Daan Westenbrink. (2014) CaMKII confirms its promise in ischaemic heart disease. European Journal of Heart Failure 16:12, pages 1268-1269.
Crossref
M. M. Maleckar, G. T. Lines, J. T. Koivumaki, J. M. Cordeiro & K. Calloe. (2014) NS5806 partially restores action potential duration but fails to ameliorate calcium transient dysfunction in a computational model of canine heart failure. Europace 16:suppl 4, pages iv46-iv55.
Crossref
Eunhyun Choi, Min-Ji Cha & Ki-Chul Hwang. (2014) Roles of Calcium Regulating MicroRNAs in Cardiac Ischemia-Reperfusion Injury. Cells 3:3, pages 899-913.
Crossref
Eleonora Grandi, Andrew G. Edwards, Anthony W. Herren & Donald M. Bers. (2014) CaMKII comes of age in cardiac health and disease. Frontiers in Pharmacology 5.
Crossref
Licette C. Y. Liu, Kevin Damman, Eric Lipsic, Alexander H. Maass, Michiel Rienstra & B. Daan Westenbrink. (2014) Heart failure highlights in 2012-2013. European Journal of Heart Failure 16:2, pages 122-132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.